MJC 2026 is a subspecialty-driven, technique-oriented arthroplasty conference designed to deliver depth-oriented learning across primary and complex joint replacement, revision arthroplasty, and perioperative optimization. MJC 2026 delivers high-value academic and industry engagement.

A focused arthroplasty-only national platform with strong academic credibility, offering meaningful engagement and sustained brand recall among joint-replacement decision-makers.

MJC 2026 is positioned as a premium arthroplasty academic platform, with sponsorship opportunities designed for quality, exclusivity, and impact. 

The scientific program will focus on:

• Primary and complex knee arthroplasty Managing complications, failures, and infections
  Implant design evolution, biomechanics, navigation, and robotics Through live and re-live surgeries, technique-driven sessions, and case-based, evidence- focused discussions

  Delegate Profile

  Arthroplasty Surgeons (Hip, Knee, Shoulder)
  Senior Consultants & High-volume Joint Replacement Surgeons
  Young Arthroplasty Surgeons & Fellows
  Academicians & Researchers
  Medical Device, Implant & Robotics Industry Professionals This audience enables direct engagement with key influencers involved in implant selection and evolving arthroplasty practice.